Ji-Hui Cao

Ji-Hui Cao

Auto-generated profile, based on publicly available information

Ji-Hui Cao

Department of Orthopaedics and Traumatology

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 June 2022 in Computational and Mathematical Methods in Medicine
Verified
Journal Article
Open access
PDF file
YZYudong Zhao
Yudong Zhao
YXYu Xia
Yu Xia
GKGaoyan Kuang
Gaoyan Kuang
JCJihui Cao
Jihui Cao
FSFu Shen
Fu Shen
MZMingshuang Zhu
Mingshuang Zhu
Background. Knee osteoarthritis (KOA) is a common degenerative joint disease. In this study, we aimed to identify new biomarkers of KOA to improve the accuracy of diagnosis and treatment. Methods. GSE98918 and GSE51588 were downloaded from the Gene Expression Omnibus database as training sets, with a total of 74 samples. Gene differences were analyzed by Gene Ontology, Kyoto Encyclopedia of Genes and Genomes pathway, and Disease Ontology enrichment analyses for the differentially expressed genes (DEGs), and GSEA enrichment analysis was carried out for the training gene set. Through least absolute shrinkage and selection operator regression analysis, the support vector machine recursive feature elimination algorithm, and gene expression screening, the range of DEGs was further reduced. Immune infiltration analysis was carried out, and the prediction results of the combined biomarker logistic regression model were verified with GSE55457. Results. In total, 84 DEGs were identified through differential gene expression analysis. The five biomarkers that were screened further showed significant differences in cartilage, subchondral bone, and synovial tissue. The diagnostic accuracy of the model synthesized using five biomarkers through logistic regression was better than that of a single biomarker and significantly better than that of a single clinical trait. Conclusions. CX3CR1, SLC7A5, ARL4C, TLR7, and MTHFD2 might be used as novel biomarkers to improve the accuracy of KOA disease diagnosis, monitor disease progression, and improve the efficacy of clinical treatment.

22 January 2021 in Medicine
Verified
Journal Article
Open access
JCJi-Hui Cao
Ji-Hui Cao
DFDa-Gang Feng
Da-Gang Feng
YWYan-Zhi Wang
Yan-Zhi Wang
HZHai-Yan Zhang
Hai-Yan Zhang
YZYu-Dong Zhao
Yu-Dong Zhao
MZMing-Shuang Zhu
Ming-Shuang Zhu
Background: As a classic prescription for treating knee osteoarthritis, Du-Huo-Ji-Sheng-decoction has been widely recognized for its clinical efficacy. The purpose of this systematic review and meta-analysis is to evaluate the effectiveness and safety of Du-Huo-Ji-Sheng-decoction in the treatment of knee osteoarthritis. Methods: The following databases will be searched from January 2011 to December 2020: PubMed, Embase, Web of Science, Cochrane Library, Chinese Biomedical Medical Database, China National Knowledge Infrastructure, Chinese Science and Technology Periodical Database, and Wanfang Database. Statistical analysis will be processed by RevMan V.5.3 software. Results: This study will provide an assessment of the current state of DHJSD in the treatment of KOA, aiming to show the efficacy and safety of DHJSD. Conclusion: This study will provide evidence to judge whether DHJSD is an effective intervention for KOA.